Related Experiment Video
Updated: Aug 21, 2026

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
A 384-well cell-based phospho-ERK assay for dopamine D2 and D3 receptors
1Department of Neuroscience, Pfizer Global Research Development, Pfizer Inc., Easter Point Road, Groton, CT 06340, USA. stephen_wong@groton.pfizer.com
Abstract:
Phosphorylation of extracellular signal-regulated kinase (ERK) is linked to activation of many cell surface receptors and kinases. However, phosphorylated ERK has not been used as a biochemical marker to monitor pharmacology of these biomolecules, largely because commonly used methods to detect the phosphoprotein are not quantitative and do not have sufficient throughput. In this article, a high-throughput, 384-well, cell-based functional assay to quantify dopamine agonist-induced ERK phosphorylation in D2- and D3-overexpressed cell lines is described. The assay uses infrared-labeled secondary antibodies to detect phospho-ERK, and the signals in the wells of the microtiter plate are quantified by a LI-COR infrared scanner. V(max), EC(50), and functional K(i) values of various D2 and D3 agonists and antagonists determined in this assay are similar to those in the literature. The assay is nonradioactive, is quantitative, and has a good signal-to-noise ratio. In addition, the signal is stable. This assay can be used to monitor the activities of many G protein-coupled receptors and other signaling biomolecules that are linked to phosphorylation of ERK. The methodology can potentially be used to detect the change in level of any cellular protein in which highly selective antibodies are available.
Insights
A new, high-throughput assay quantifies extracellular signal-regulated kinase (ERK) phosphorylation, enabling precise monitoring of dopamine receptor pharmacology and other signaling pathways.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Extracellular signal-regulated kinase (ERK) phosphorylation is a key indicator of cell surface receptor and kinase activation.
- Existing methods for detecting phospho-ERK lack the quantification and throughput needed for robust pharmacological studies.
Purpose of the Study:
- To develop a high-throughput, quantitative assay for measuring dopamine agonist-induced ERK phosphorylation.
- To validate the assay's utility for determining pharmacological parameters of D2 and D3 receptor ligands.
Main Methods:
- A 384-well, cell-based functional assay utilizing infrared-labeled secondary antibodies to detect phospho-ERK.
- Quantification of signals using a LI-COR infrared scanner in D2- and D3-overexpressed cell lines.
Main Results:
- The assay accurately determined V(max), EC(50), and functional K(i) values for D2 and D3 agonists and antagonists, consistent with literature values.
- The assay demonstrated to be nonradioactive, quantitative, stable, and possess a good signal-to-noise ratio.
Conclusions:
- This novel assay provides a reliable and efficient method for monitoring ERK phosphorylation.
- The methodology is applicable to studying a wide range of G protein-coupled receptors and other signaling biomolecules linked to ERK phosphorylation.
- The technique has potential for detecting changes in any cellular protein using selective antibodies.
More Related Videos
09:03Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013